SuspendedEarly Phase 1

Body Composition and Sport Performance Among Young Female Soccer Players Using Subdermic Etonogestrel

Stopped: The study was suspended due to non-compliance with the partnership agreement between the research team and the company that would supply Implanon. Therefore, it was not possible to continue the study

Brazil40 participantsStarted 2025-04-01

Plain-language summary

The goal of this clinical trial study is to evaluate the effect of subdermic etonogestrel implant on body composition, sport performance parameters, quantify bleeding patters and quality of life parameters among young female soccer players.

Who can participate

Age range16 Years – 17 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: \- sexually active women of childbearing potential, with no contraindications to the use of a progestogen and who agreed to participate in this study. Exclusion Criteria: * breastfeeding, irregular vaginal bleeding, increased risk of thromboembolism, ischemic heart disease or other medical conditions

What they're measuring

Anthropometric Measurements

Timeframe: Clinical, body composition and sport parameters will be evaluation before, 3, 6, 9 and 12 months after implant insertion.

anthropometric measurements

Timeframe: Will be evaluation before, 3, 6, 9 and 12 months after implant insertion.

anthropometric measurements

Timeframe: Will be evaluation before, 3, 6, 9 and 12 months after implant insertion.

Body Composition

Timeframe: Will be evaluation before, 3, 6, 9 and 12 months after implant insertion.

anthropometric measurements

Timeframe: will be evaluated before, 3, 6, 9 and 12 months after implant insertion.

Trial details

NCT IDNCT06775626

SponsorMaíta Poli de Araújo

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2025-04-01

View on ClinicalTrials.gov More Menstrual Symptoms trials